Bortezomib for injection is available in 3.5 mg strength, packaged in a single-dose vial.
PISCATAWAY, N.J. –Camber Pharmaceuticals is excited to announce the addition of bortezomib for injection.
Bortezomib for injection is a proteasome inhibitor indicated for:
• treatment of adult patients with multiple myeloma
• treatment of adult patients with mantle cell lymphoma
Bortezomib for injection is available in 3.5 mg strength, packaged in a single-dose vial.
The meeting will feature perspectives linking leadership, innovation, and history during a pivotal time for the country and pharmacy industry.
Historic PBM reforms enacted last week mark a major milestone — and swift implementation and additional reforms remain essential.
Backed by EmpiRx Health’s frontline pharmacists and AI-powered technologies, “MO” optimizes the patients’ drug mix to improve member health outcomes and lower costs.
During remarks delivered at last month’s FMI Midwinter Executive Conference, Boyan, who is also the association’s chairman, spoke about what motivates the company.
In an AI-mediated marketplace, Sebok suggested, that distinction may be the difference between relevance and invisibility.
David Pinto looks ahead to the significance of the NACDS Annual Meeting in April.
New research from the Kearney Consumer Institute uncovers some hidden aspects of the trend, which, of course, has serious implications for both mass market retailers and consumer packaged goods companies.
